D-cycloserine does not facilitate fear extinction by reducing conditioned stimulus processing or promoting conditioned inhibition to contextual cues

Learning and Memory

Volumn 19, Issue 10, 2012, Pages 461-469

  Baker, Kathryn D ^a   McNally, Gavan P ^a   Richardson, Rick ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSOCIATION; CONDITIONING; CONTROLLED STUDY; EXPOSURE; FEAR; FOOTSHOCK; FREEZING; INHIBITION (PSYCHOLOGY); LATENT INHIBITION; LEARNING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; SKILL RETENTION; STIMULUS;

ANALYSIS OF VARIANCE; ANIMALS; ANTIMETABOLITES; CONDITIONING (PSYCHOLOGY); CUES; CYCLOSERINE; DRUG ADMINISTRATION SCHEDULE; EXTINCTION, PSYCHOLOGICAL; FEAR; FREEZING REACTION, CATALEPTIC; INHIBITION (PSYCHOLOGY); MALE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 84867640555     PISSN: 10720502     EISSN: 15495485     Source Type: Journal    
DOI: 10.1101/lm.026674.112     Document Type: Article

References (61)

1. Baker JD, Azorlosa JL. 1996. The NMDA antagonist MK-801 blocks the extinction of Pavlovian fear conditioning. Behav Neurosci 110: 618-620. (Pubitemid 26227108)
2. Barak S, Weiner I. 2010. Dissociating scopolamine-induced disrupted and persistent latent inhibition: Stage-dependent effects of glycine and physostigmine. Psychopharmacology 209: 175-184.
3. Bertotto ME, Bustos SG, Molina VA, Martijena ID. 2006. Influence of ethanol withdrawal on fear memory: Effect of D-cycloserine. Neuroscience 142: 979-990. (Pubitemid 44642332)
4. Bouton ME. 2002. Context, ambiguity, and unlearning: Sources of relapse after behavioral extinction. Biol Psychiatry 52: 976-986. (Pubitemid 35356355)
5. Bouton ME, Bolles RC. 1979a. Contextual control of the extinction of conditioned fear. Learn Motiv 10: 445-466.
6. Bouton ME, Bolles RC. 1979b. Role of conditioned contextual stimuli in reinstatement of extinguished fear. J Exp Psychol Anim Behav Process 5: 368-378.
7. Bouton ME, Westbrook RF, Corcoran KA, Maren S. 2006. Contextual and temporal modulation of extinction: Behavioral and biological mechanisms. Biol Psychiatry 60: 352-360. (Pubitemid 44215847)
8. Bouton ME, Vurbic D, Woods AM. 2008. D-cycloserine facilitates context-specific fear extinction learning. Neurobiol Learn Mem 90: 504-510.
9. Chang C-H, Maren S. 2011. Medial prefrontal cortex activation facilitates re-extinction of fear in rats. Learn Mem 18: 221-225.
10. de Kleine RA, Hendriks G-J, Kusters WJC, Broekman TG, van Minnen A. 2012. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry 71: 962-968.
11. Delamater AR. 2012. Issues in the extinction of specific stimulus-outcome associations in Pavlovian conditioning. Behav Processes 90: 9-19.
12. Falls W, Miserendino M, Davis M. 1992. Extinction of fear-potentiated startle: Blockade by infusion of an NMDA antagonist into the amygdala. J Neurosci 12: 854-863.
13. Fanselow M. 1980. Conditional and unconditional components of post-shock freezing. Pavlov J Biol Sci 15: 177-182. (Pubitemid 11190893)
14. Gaisler-Salomon I, Weiner I. 2003. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol. Psychopharmacology 166: 333-342. (Pubitemid 36469935)
15. Gaisler-Salomon I, Diamant L, Rubin C, Weiner I. 2008. Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: Differential efficacy depending on the stage of the task at which they are administered. Psychopharmacology 196: 255-267.
16. Graham BM, Langton JM, Richardson R. 2011. Pharmacological enhancement of fear reduction: Preclinical models. Br J Pharmacol 164: 1230-1247.
17. Guastella AJ, Richardson R, Lovibond PF, Rapee RM, Gaston JE, Mitchell P, Dadds MR. 2008. A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder. Biol Psychiatry 63: 544-549.
18. Hofmann SG, Smits JAJ. 2008. Cognitive-behavioral therapy for adult anxiety disorders: A meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry 69: 621-632. (Pubitemid 351792338)
19. Hofmann SG, Meuret AE, Smits JAJ, Simon NM, Pollack MH, Eisenmenger K, Shiekh M, Otto MW. 2006. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry 63: 298-304. (Pubitemid 43345354)
20. Holtzman O, Siette J, Holmes NM, Westbrook RF. 2010. Additional exposures reverse the latent inhibitory effects of recent and remote exposures. J Exp Psychol Anim Behav Process 36: 368-380.
21. Kaplan GB, Moore KA. 2011. The use of cognitive enhancers in animal models of fear extinction. Pharmacol Biochem Behav 99: 217-228.
22. Kim JH, Li S, Richardson R. 2011. Immunohistochemical analyses of long-term extinction of conditioned fear in adolescent rats. Cereb Cortex 21: 530-538.
23. Kuriyama K, Honma M, Soshi T, Fujii T, Kim Y. 2011. Effect of D-cycloserine and valproic acid on the extinction of reinstated fear-conditioned responses and habituation of fear conditioning in healthy humans: A randomized controlled trial. Psychopharmacology 218: 589-597.
24. Kushner MG, Kim SW, Donahue C, Thuras P, Adson D, Kotlyar M, McCabe J, Peterson J, Foa EB. 2007. D-Cycloserine augmented exposure therapy for obsessive-compulsive disorder. Biol Psychiatry 62: 835-838. (Pubitemid 47488217)
25. Lai CS, Franke TF, Gan WB. 2012. Opposite effects of fear conditioning and extinction on dendritic spine remodelling. Nature 483: 87-91.
26. Ledgerwood L, Richardson R, Cranney J. 2003. Effects of D-cycloserine on extinction of conditioned freezing. Behav Neurosci 117: 341-349. (Pubitemid 36384252)
27. Ledgerwood L, Richardson R, Cranney J. 2004. D-Cycloserine and the facilitation of extinction of conditioned fear: Consequences for reinstatement. Behav Neurosci 118: 505-513. (Pubitemid 38685318)
28. Ledgerwood L, Richardson R, Cranney J. 2005. D-cycloserine facilitates extinction of learned fear: Effects on reacquisition and generalized extinction. Biol Psychiatry 57: 841-847. (Pubitemid 40488352)
29. Lin C-H, Yeh S-H, Leu T-H, Chang W-C, Wang S-T, Gean P-W. 2003. Identification of calcineurin as a key signal in the extinction of fear memory. J Neurosci 23: 1574-1579. (Pubitemid 36314710)
30. Lubow RE. 1965. Latent inhibition: Effects of frequency of nonreinforced pre-exposure of the CS. J Comp Physiol Psychol 60: 454-457.
31. Lubow RE, Moore AU. 1959. Latent inhibition: The effect of nonreinforced pre-exposure to the conditional stimulus. J Comp Physiol Psychol 52: 415-419.
32. Mao S-C, Hsiao Y-H, Gean P-W. 2006. Extinction training in conjunction with a partial agonist of the glycine site on the NMDA receptor erases memory trace. J Neurosci 26: 8892-8899. (Pubitemid 44319377)
33. McCallum J, Kim JH, Richardson R. 2010. Impaired extinction retention in adolescent rats: Effects of D-cycloserine. Neuropsychopharmacology 35: 2134-2142.
34. Myers KM, Davis M. 2002. Behavioral and neural analysis of extinction. Neuron 36: 567-584. (Pubitemid 35346753)
35. Myers KM, Carlezon WA Jr, Davis M. 2011. Glutamate receptors in extinction and extinction-based therapies for psychiatric illness. Neuropsychopharmacology 36: 274-293.
36. National Health and Medical Research Council (Australia). 2004. Australian code of practice for the care and use of animals for scientific purposes, 7th ed. National Health and Medical Research Council, Canberra, Australia.
37. Otto MW, Tolin DF, Simon NM, Pearlson GD, Basden S, Meunier SA, Hofmann SG, Eisenmenger K, Krystal JH, Pollack MH. 2010. Efficacy of D-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biol Psychiatry 67: 365-370.
38. Pearce JM, Hall G. 1980. A model for Pavlovian learning: Variations in the effectiveness of conditioned but not of unconditioned stimuli. Psychol Rev 87: 532-552.
39. Polack C, Laborda M, Miller R. 2012. Extinction context as a conditioned inhibitor. Learn Behav 40: 24-33.
40. Quirk GJ. 2002. Memory for extinction of conditioned fear is long-lasting and persists following spontaneous recovery. Learn Mem 9: 402-407. (Pubitemid 35425106)
41. Quirk GJ, Mueller D. 2008. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 33: 56-72. (Pubitemid 350191313)
42. Rescorla RA. 1969. Pavlovian conditioned inhibition. Psychol Bull 72: 77-94.
43. Rescorla RA. 1973. Effect of US habituation following conditioning. J Comp Physiol Psychol 82: 137-143.
44. Rescorla RA. 2004. Spontaneous recovery. Learn Mem 11: 501-509. (Pubitemid 39299696)
45. Rescorla RA, Heth CD. 1975. Reinstatement of fear to an extinguished conditioned stimulus. J Exp Psychol Anim Behav Process 1: 88-96.
46. Rescorla RA, Wagner AR. 1972. A theory of Pavlovian conditioning: Variations in the effectiveness of reinforcement and nonreinforcement. In Classical conditioning II: Current research and theory (ed. AH Black, WF Prokasy), pp. 64-99. Appleton Century Crofts, New York, NY.
47. Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E, Hodges L, Davis M. 2004. Cognitive enhancers as adjuncts to psychotherapy: Use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 61: 1136-1144. (Pubitemid 39463415)
48. Richards RW, Sargent DM. 1983. The order of presentation of conditioned stimuli during extinction. Anim Learn Behav 11: 229-236.
49. Richardson R, Ledgerwood L, Cranney J. 2004. Facilitation of fear extinction by D-cycloserine: Theoretical and clinical implications. Learn Mem 11: 510-516. (Pubitemid 39299697)
50. Robbins SJ. 1990. Mechanisms underlying spontaneous recovery in autoshaping. J Exp Psychol Anim Behav Process 16: 235-249.
51. Siegmund A, Golfels F, Finck C, Halisch A, Räth D, Plag J, Ströhle A. 2011. D-Cycloserine does not improve but might slightly speed up the outcome of in-vivo exposure therapy in patients with severe agoraphobia and panic disorder in a randomized double blind clinical trial. J Psychiatr Res 45: 1042-1047.
52. Sotres-Bayon F, Bush DEA, LeDoux JE. 2007. Acquisition of fear extinction requires activation of NR2B-containing NMDA receptors in the lateral amygdala. Neuropsychopharmacology 32: 1929-1940.
53. Sotres-Bayon F, Diaz-Mataix L, Bush DEA, LeDoux JE. 2009. Dissociable roles for the ventromedial prefrontal cortex and amygdala in fear extinction: NR2B contribution. Cereb Cortex 19: 474-482.
54. Storsve AB, McNally GP, Richardson R. 2010. US habituation, like CS extinction, produces a decrement in conditioned fear responding that is NMDA dependent and subject to renewal and reinstatement. Neurobiol Learn Mem 93: 463-471.
55. Storsve AB, McNally GP, Richardson R. 2012. Renewal and reinstatement of the conditioned but not the unconditioned response following habituation of the unconditioned stimulus. Behav Process 90: 58-65.
56. Vervliet B. 2008. Learning and memory in conditioned fear extinction: Effects of D-cycloserine. Acta Psychol 127: 601-613.
57. Vetere G, Restivo L, Novembre G, Aceti M, Lumaca M, Ammassari-Teule M. 2011. Extinction partially reverts structural changes associated with remote fear memory. Learn Mem 18: 554-557.
58. Walker DL, Ressler KJ, Lu K-T, Davis M. 2002. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci 22: 2343-2351.
59. Weber M, Hart J, Richardson R. 2007. Effects of D-cycloserine on extinction of learned fear to an olfactory cue. Neurobiol Learn Mem 87: 476-482.
60. Westbrook RF, Jones ML, Bailey GK, Harris JA. 2000. Contextual control over conditioned responding in a latent inhibition paradigm. J Exp Psychol Anim Behav Process 26: 157-173.
61. Woods AM, Bouton ME. 2006. D-cycloserine facilitates extinction but does not eliminate renewal of the conditioned emotional response. Behav Neurosci 120: 1159-1162.